Clinical Trial Update: Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating add-on dapagliflozin to liraglutide and insulin in adults with Type 1 diabetes; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Insulin (insulin)
• liraglutide (liraglutide)

Snippet

Sponsor: University at Buffalo | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2024-01-24